Femasys (FEMY) Change in Account Payables (2020 - 2026)
Femasys' (FEMY) quarterly Change in Account Payables came in at -$253439.0 in Q1 2026, down 128.45% YoY from $890678.0 in Q1 2025, and up 21.19% on a QoQ basis from -$321574.0 in Q4 2025.
Femasys (FEMY) Change in Account Payables (2020 - 2026) Analysis & Trends
Femasys (FEMY) has 7 years of Change in Account Payables data on file, last reported at -$253439.0 in Q1 2026.
- Quarterly Change in Account Payables fell 128.45% year-over-year to -$253439.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$809288.0 (down 165.48% YoY) and the FY2025 annual result came in at $334829.0, up 61.38% from the prior year.
- Change in Account Payables advanced to -$253439.0 in Q1 2026, from -$321574.0 in the prior quarter.
- In the past five years, Change in Account Payables ranged from a high of $890678.0 in Q1 2025 to a low of -$1.1 million in Q3 2025.
- A 5-year average of $57716.0 and a median of $33103.0 in 2023 frame the typical range for Change in Account Payables.
- Annual changes were most pronounced in 2022 — Change in Account Payables jumped 1228.6% — and 2024, when it sank 4667.41%.
- Tracing FEMY's Change in Account Payables over 5 years: stood at $114685.0 in 2022, then surged by 149.33% to $285946.0 in 2023, then declined by 9.33% to $259280.0 in 2024, then plunged by 224.03% to -$321574.0 in 2025, then climbed by 21.19% to -$253439.0 in 2026.
- The last three Change in Account Payables figures came in at -$253439.0 (Q1 2026), -$321574.0 (Q4 2025), and -$1.1 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | -52.50 Mn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | - |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | - |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | - |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | 83.00 Mn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | - |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | -17.00 Mn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | - |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | -52.00 Mn |
| 10 | Femasys | 9.97 Mn | 8.53 Mn | 189,391.00 | 752,689.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -253,439.00 |
| Mar 31, 2026 | -253,439.00 |
| Dec 31, 2025 | -321,574.00 |
| Dec 31, 2025 | -321,574.00 |
| Sep 30, 2025 | -1.10 Mn |
| Sep 30, 2025 | -1.10 Mn |
| Jun 30, 2025 | 867,484.00 |
| Jun 30, 2025 | 867,484.00 |
| Mar 31, 2025 | 890,678.00 |
| Mar 31, 2025 | 890,678.00 |
| Dec 31, 2024 | 259,280.00 |
| Dec 31, 2024 | 259,280.00 |
| Sep 30, 2024 | 171,883.00 |
| Sep 30, 2024 | 171,883.00 |
| Jun 30, 2024 | -85,929.00 |
| Jun 30, 2024 | -85,929.00 |
| Mar 31, 2024 | -137,753.00 |
| Mar 31, 2024 | -137,753.00 |
| Dec 31, 2023 | 285,946.00 |
| Dec 31, 2023 | 285,946.00 |